AI assistant
Sending…
FENNEC PHARMACEUTICALS INC. — Director's Dealing 2010
Aug 20, 2010
35599_dirs_2010-08-20_89713566-abe3-496c-bc4d-0ef8b8db5040.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4/A — Form 4/A
Issuer: ADHEREX TECHNOLOGIES INC (ADHXF)
CIK: 0001211583
Period of Report: 2010-08-18
Reporting Person: BREEN WILLIAM G (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2010-08-18 | Stock Options (right to buy) | $0.045 | A | 0 | Acquired | 2017-08-18 | Common Stock (4603668) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 667623 | Direct |
| Common Stock | 192907 | Indirect |
| Common Stock | 507251 | Indirect |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Options (right to buy) | $0.57 | 2014-05-15 | Common Stock (200000) | 200000 | Direct |
| Stock Options (right to buy) | $0.28 | 2014-12-03 | Common Stock (50000) | 50000 | Direct |
Footnotes
F1: The options will vest 100% on the date reported above and were issued in AHX (TSX listed shares).
F2: in CDN
More from FENNEC PHARMACEUTICALS INC.
Regulatory Filings
2026
May 22
Regulatory Filings
2026
May 18
Interim / Quarterly Report
2026
May 14
Regulatory Filings
2026
Apr 28
Regulatory Filings
2026
Apr 7
Annual Report
2026
Mar 27
Regulatory Filings
2026
Mar 24
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Regulatory Filings
2026
Feb 20